Today: 7 February 2026
Subscribe

SoFi stock slides ahead of Friday earnings as options price in a big SOFI move

SoFi stock slides ahead of Friday earnings as options price in a big SOFI move

SoFi Technologies shares fell 1.7% to $24.19 Thursday ahead of its fourth-quarter and full-year 2025 earnings report due Friday morning. Options markets are pricing in an 8.6% swing after results, with analyst ratings split and Bank of America assigning a sell rating. Fitch finalized ratings for SoFi’s new $347.5 million consumer-loan securitization. Trading volume topped 52 million shares.
29 January 2026
··
Microchip Technology stock slips today: MCHP falls with tech as Feb. 5 earnings loom

Microchip Technology stock slips today: MCHP falls with tech as Feb. 5 earnings loom

Microchip Technology shares fell 2.2% to $78.55 Thursday amid a broader tech sell-off sparked by Microsoft’s earnings update. The drop comes a week before Microchip’s quarterly results on Feb. 5. The company recently raised its Q3 sales forecast and launched new microcontrollers targeting industrial markets. BofA Securities upgraded the stock to “Buy” on Wednesday, raising its price target to $95.
29 January 2026
···
Ondas (ONDS) stock price drops as Optimus drone hits DCMA Blue UAS cleared list

Ondas (ONDS) stock price drops as Optimus drone hits DCMA Blue UAS cleared list

Ondas Inc shares fell about 8% to $11.29 Thursday after its American Robotics Optimus drone was added to the DCMA’s Blue List of approved unmanned systems. Trading volume topped 74 million shares. The company also disclosed details of its $224.6 million acquisition of Israel-based Sentry CS Ltd in a new SEC filing. Next earnings report is scheduled for March 11.
29 January 2026
··
Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics stock price rises as FDA freezes rival Regenxbio’s Hunter syndrome gene therapy trials

Denali Therapeutics shares rose 3.7% to $21.62 Thursday after the FDA halted Regenxbio’s gene therapy trials over a brain tumor case, intensifying focus on Denali’s Hunter syndrome drug under FDA review. Investors await Denali’s clinical data update in early February and a regulatory decision by April 5. The iShares Nasdaq Biotechnology ETF was little changed.
29 January 2026
····
IBM stock rises after earnings beat, as Wall Street zeroes in on Red Hat and Washington risk

IBM stock rises after earnings beat, as Wall Street zeroes in on Red Hat and Washington risk

IBM shares rose 3.3% to $304.01 Thursday after reporting fourth-quarter revenue of $19.7 billion and adjusted earnings of $4.52 per share, beating forecasts. The gain contrasted with declines in other software stocks as investors questioned AI investment returns. Red Hat growth slowed to 10%, partly due to a U.S. government shutdown. IBM will stop reporting its “AI book of business” separately starting next quarter.
29 January 2026
···
Capital One stock today: COF near $219 as Fed pause resets rate bets, Visa and AmEx earnings next

Capital One stock today: COF near $219 as Fed pause resets rate bets, Visa and AmEx earnings next

Capital One shares edged up 0.2% to $218.76 Thursday, trading between $217.44 and $223.00 on 2.3 million shares. Mastercard jumped 3.9% after beating profit forecasts and announcing job cuts. The Fed held rates steady, with traders watching for a possible cut in June. Capital One remains 16% below its January high.
29 January 2026
······
Analog Devices stock slips from a fresh high as AI spending jitters weigh on chip shares

Analog Devices stock slips from a fresh high as AI spending jitters weigh on chip shares

Analog Devices shares fell 0.5% to $316.17 Thursday, retreating after a 4.5% surge to a 52-week high the previous day. Chip stocks broadly slipped as investors questioned the pace of returns from heavy AI investments. Traders await Analog Devices’ Feb. 18 results for signals on demand. The iShares Semiconductor ETF dipped 0.7%, while Texas Instruments gained 0.9%.
29 January 2026
···
1 … 247 248 249 250 251 … 2,715

Stock Market Today

GE Vernova stock price jumps toward $800 — what to know before Monday trade

GE Vernova stock price jumps toward $800 — what to know before Monday trade

7 February 2026
GE Vernova shares jumped 5.7% to $779.35 Friday after Baird upgraded the stock and the Dow closed above 50,000. The company’s onshore wind unit reported 1.1 GW in U.S. repower orders for 2025, a figure previously disclosed. GE Vernova also completed a $2.6 billion senior notes offering to help fund its Prolec GE stake purchase. Next earnings report is set for April 22.
Go toTop